mots-c research: Frequently asked questions

Add post-intervention washout assessment if study timeline permits. Subjects return to baseline mitochondrial function 4–6 weeks after MOTS-C discontinuation in most metabolic studies. This retrospective baseline measurement reduces precision but maintains study validity. Document the limitation explicitly in your methodology section, because reviewers will flag the absence of baseline data as a confounding variable when assessing dose-response claims.

Document the temperature excursion with exact duration and ambient temperature, then perform concentration verification via UV spectroscopy before continuing the study. MOTS-C shows approximately 8–12% potency degradation per hour at 20–25°C based on accelerated stability data published in Peptides journal. If you're past the 12-hour mark at room temperature, the batch is compromised. Continuing without disclosure creates a replication issue for future studies citing your protocol.

Use freshly opened bacteriostatic water with manufacturer pH specification and document the unopened-to-mixing timeframe. Bacteriostatic water pH drifts toward acidity after bottle opening due to CO₂ absorption. Use within 24 hours of first opening to minimize variance. If pH testing equipment isn't available, source pre-verified buffered diluent from pharmaceutical-grade suppliers rather than assuming generic sterile water meets the 6.8–7.2 pH requirement.

Reconstituted peptides tolerate short-term ambient temperature (up to 25°C for 24–48 hours) but degrade rapidly above that threshold. Use a portable insulin cooler with gel packs that maintain 2–8°C for 36–48 hours without electricity. FRIO wallets use evaporative cooling and work for up to 5 days if kept moist. Never freeze reconstituted MOTS-C. Ice crystal formation ruptures peptide bonds. If the vial reaches room temperature for more than 4 hours during transport, assume partial degradation and adjust your protocol timeline accordingly.

For ultra-low doses (50mcg or less), reconstitute at 0.5mg/mL or lower. A 5mg vial reconstituted in 10mL yields 0.5mg/mL, and a 50mcg dose requires only 0.1mL. Manageable with insulin syringes. Attempting to draw 0.025mL from a 2mg/mL solution introduces unacceptable measurement error. Lower concentrations trade shelf life for precision: you'll use the vial faster, but each dose will be more accurate.

If you added too much bacteriostatic water and your concentration is lower than intended, you can still use the vial. Just adjust your injection volume upward to match your target dose. For example, if you intended 2mg/mL (2.5mL reconstitution for 5mg) but accidentally added 5mL (resulting in 1mg/mL), double your injection volume to maintain the same dose. The peptide itself remains stable as long as you used bacteriostatic water and stored it properly. Do not attempt to remove excess liquid or add more peptide to correct the concentration. Contamination risk outweighs the benefit.